期刊
BBA CLINICAL
卷 6, 期 -, 页码 31-37出版社
ELSEVIER
DOI: 10.1016/j.bbacli.2016.05.005
关键词
Heart failure with reduced ejection fraction; Heart failure with preserved ejection fraction; Epigenetic modifications; Chromatin remodeling
Chronic heart failure (HF) is a leading clinical and public problemposing a higher risk of morbidity and mortality in different populations. HF appears to be in both phenotypic forms: HF with reduced left ventricular ejection fraction (HFrEF) and HF with preserved left ventricular ejection fraction (HFpEF). Although both HF phenotypes can be distinguished through clinical features, co-morbidity status, prediction score, and treatment, the clinical outcomes in patients with HFrEF and HFpEF are similar. In this context, investigation of various molecular and cellular mechanisms leading to the development and progression of both HF phenotypes is very important. There is emerging evidence that epigenetic regulation may have a clue in the pathogenesis of HF. This review represents current available evidence regarding the implication of epigenetic modifications in the development of different HF phenotypes and perspectives of epigenetic-based therapies of HF. (C) 2016 The Author. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据